Business ❯Pharmaceutical Industry ❯Regulations

FDA

Drug Approval Process

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

The pharmaceutical company argues that compounded semaglutide poses significant safety risks due to its complexity.